# Product recall referral timing: an 8-check test | SourceX

Canonical: https://refer.sourcex.si/guides/the-referral-questions-after-a-product-recall-review
Last updated: 2026-11-05

Treat a product recall review as a reason to wait, not an opening. The licensing question becomes fair only after the recall is closed, the company has finished looking back at it, nothing about the product is still being fought over, and the CEO has talked about the review with you or in public. Even then, ask the CEO once, in a conversation that does not lean on the recall, and take a no as final. A recall never makes a company's records more likely to fit.

This page is for partners who hear about recalls early: accountants, consultants, insurance brokers and investors with a board relationship. It covers timing and authority only. The files a recall produces belong to the company and its counsel; a partner never reviews, exports or summarizes them, and never offers to.

## What the outside world can see of a recall, and what it cannot

A recall is the company taking a product back or fixing it; the review is its own look at what failed and what changes as a result. Part of that is public. For products FDA oversees, its enforcement report definitions separate two endpoints. FDA defines a completed recall as "A recall which has reached the point at which the firm has actually retrieved and impounded all outstanding product that could reasonably be expected to be recovered." Termination comes afterward and is FDA's own determination that the recall can be closed (paraphrased from the same definitions). For other products, take the status from the company's announcements or from the CEO, never from guesswork.

What stays invisible from outside is what matters most for timing: whether the review is finished, whether claims or inquiries are still open, and how stretched the people around the CEO remain. Those answers come from the CEO, when the CEO chooses to give them.

Two things make the weeks straight after a recall a poor moment. The question would land on people still handling the recall, and it would read as a partner trying to profit from the company's worst quarter. And much of what a recall leaves behind is sensitive by nature: complaint files that name consumers, letters from regulators, material shared under customers' contracts. SourceX's screening page lists personal consumer data and material that belongs to a company's clients among what is usually not a fit, so the recall archive is the last thing a partner should point at.

## The sensitive-event appropriateness checklist

Eight checks, each answered from what the CEO has told you or what the company has said publicly. One check in the hold column means hold.

| # | Check | Ask once when | Hold when | Where the answer comes from |
|---|---|---|---|---|
| 1 | How you learned of the review | The CEO told you, or the company announced it | Someone told you in confidence | Your own dated notes |
| 2 | Recall status | Completed, and closed by the agency where one oversees it | Product is still being retrieved or corrected | The company's notices or the CEO |
| 3 | The company's own review | Finished, with its follow-up actions assigned | Still running, or its findings are disputed inside the company | The CEO |
| 4 | Open matters about the product | None that the CEO mentions | A lawsuit, regulator inquiry or insurance claim is still open | The CEO, or public court and agency records |
| 5 | Who would hear the question | The CEO alone | It would reach the quality, regulatory or recall team first | Your own plan |
| 6 | Why the company came to mind | You knew its fit facts before the recall | The recall is the only reason you thought of it | Notes dated before the recall |
| 7 | Your part in the recall | None, or a paid role you keep fully apart and disclose | You advise on the recall, and your engagement terms or the client would object | Your engagement letter |
| 8 | The aftermath | The CEO talks calmly about lessons learned | Layoffs, lost customers or leadership changes tied to the recall are still unfolding | The CEO and company announcements |

For each hold, write down the event that would turn it, such as the suit settling, the review being signed off or a date the CEO gave, and ask nothing until it happens. Check 6 is the one partners skip. If the company's size at its peak, the age of its records and its rights to them were unknown to you until the recall made headlines, the recall is doing the work of a reason, and the question will sound exactly like that.

**Method note.** The checks combine SourceX's screening page and program terms (Version 2026-10-22.2, since replaced by version 2026-11-04), FDA's enforcement report definitions, SourceX's guide to licensing in regulated industries and the sample Channel Partner Agreement, all read on 2026-10-27. Nobody has published how CEOs respond to a licensing question after a recall. The checklist is a method, not a measured result, and each threshold in it is a judgment a partner should be able to defend to the CEO's face.

## Why the recall is never part of the pitch

A recall moves nothing in the published screen. A company still needs 50 or more full-time employees at its peak, contractors excluded, a run of several years of its own records, clear rights to license that material and a CEO who is willing to talk. Companies in the U.S., Canada and the EU qualify, as do companies in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia when at least 70% of the data is in English.

Regulated and confidential material is for SourceX to assess in its own qualification, with the company. Its guide to licensing in regulated industries says "Rights and laws are reviewed deal by deal with counsel" and lists "Some records cannot be licensed at all" among the points to know. A partner cannot predict where that review lands and cannot promise anything about it: the sample Channel Partner Agreement says "Partner is not an agent of SourceX and may not commit SourceX to prices, licenses, payouts or other obligations" (section 7.1). Nothing on this page is legal or regulatory advice; what the company may discuss about its recall is for its own counsel to say.

So the recall stays out of the question altogether. If the company later applies, it describes itself to SourceX in its own words. For the general case of records a company considers too sensitive, see [whether a company's data is too sensitive to license](/questions/is-my-company-data-too-sensitive-to-license); for a past security incident rather than a recall, [licensing after a data breach](/questions/can-a-company-with-a-data-breach-license-data) covers the scoping side, and [incident response histories](/guides/incident-response-histories-sensitive-context-requires-a-careful-handoff) shows why sensitive context needs a careful handoff.

## One decider, and the people who should never hear it first

- **The CEO decides.** If the company has been acquired since the recall, the acquirer's CEO decides for it; if a sale is signed but has not closed, the target's CEO still decides. A parent and all its subsidiaries share one reward cap.
- **The head of quality or regulatory affairs** may become the internal sponsor if the CEO wants to explore. That person is never the first to hear the question and never the one who says yes.
- **Never asked:** the recall coordinator, plant or site managers, distributors, retailers, the company's customers or the agency. Each of them would turn a private question into a conversation the CEO never authorized.

Once a CEO wants the conversation, the specialist side of quality records is set out in [the quality assurance exceptions conversation](/guides/quality-assurance-exceptions-a-specialist-referral-conversation).

## Three recalls run through the checklist (Illustrative)

Illustrative. Generic companies, invented facts, no outcomes implied.

| Check | A 300-person maker of commercial kitchen equipment | A 180-person medical supplies manufacturer | A 520-person household goods company |
|---|---|---|---|
| How you learned | The CEO, over a client dinner | A press release | A consulting engagement |
| Recall status | Completed 18 months ago, closed | Completed last spring | Product still being retrieved |
| Company's own review | Signed off, actions assigned | Finished | Under way |
| Open matters | None mentioned | A product liability suit | Unknown |
| Your part in the recall | None; you are its auditor | None | You advise on recall communications |
| Fit known before the recall | Yes, since 2022 | Yes | No |
| Result | Ask the CEO once | Hold until the CEO says the suit is resolved | Hold, and keep any later question out of the engagement |

The kitchen equipment maker passes because every answer came from the CEO or the company, and the question can be put without the recall in it. The medical supplies maker clears every check except number 4, and one hold is enough. The household goods company fails three checks, and the consultant's role means that even a later question needs its own, disclosed conversation, never a line added to recall work.

## The question, once, and the note you keep

Illustrative wording, for a conversation that has nothing to do with the recall:

> Unrelated to anything we have worked on together: would the company want to explore licensing some of its own operating records to SourceX for AI training and evaluation? You can say no, and that ends it. One disclosure: if it went ahead, SourceX could pay me a referral reward, separately from anything it pays the company, and what the company receives would not change because of me.

That disclosure leans on section 4 of the terms, which states: "The referral reward is paid separately by SourceX and is never deducted from the supplier's agreed compensation."

Afterward, write four lines: the date, the CEO's answer in the CEO's words, the next step and whose it is, and anything the CEO asked you to avoid. If the answer is yes, sign the Channel Partner Agreement before submitting anything, and let the company apply itself. Under section 2, credit is settled from dated records: the earliest valid introduction wins if it falls within the 90-day attribution window and the company then files a verified application. Under section 3, a company already in contact with SourceX is a duplicate. If the answer is "next year", record the date the CEO named and stay silent until it comes. Other business changes that can open the question are gathered in the [guides hub](/guides).

## When the checklist points the wrong way

- **Closed is not over for everyone.** A recall can be closed while suits or claims carry on; check 4 exists for that reason, and it can turn after you have asked.
- **A clean checklist is not a fit.** Size at peak, years of records, rights and current demand are assessed only in SourceX's review, and each program applies its own criteria.
- **Crisis advisors carry extra weight.** A CEO who leaned on you during the recall may find it hard to refuse you. Make the no explicit, and if you sense obligation, wait longer.
- **Headlines run ahead of reviews.** A press release can announce a completed recall while the company's own review runs on for months. The CEO's account outranks the announcement.
- **Undated notes fail checks 1 and 6.** Without a dated record of how you learned and what you knew before, assume hold.

## Next step

> **Refer a company. No cap on rewards.** Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.

When all eight checks sit in the ask column, [register as a partner](/register), set your dated notes beside [who qualifies](/who-qualifies) and read the [program terms](/terms) before the CEO hears a word.

## Sources

- https://refer.sourcex.si/terms
- https://refer.sourcex.si/who-qualifies
- https://sourcex.si/guides/scenarios/licensing-data-in-a-regulated-industry
- https://www.fda.gov/safety/enforcement-reports/enforcement-report-information-and-definitions
- https://sourcex.si/documents/partner/SourceX_Channel_Partner_Agreement_Sample.pdf
